Sesame protein-derived peptides show promise in fighting E. coli and S. aureus

A study in “Nutrients” reveals that sesame protein-derived peptides, Ala-Gly-Gly-Val-Pro-Arg and Ser-Thr-Ile-Arg, show effective antibacterial activity against Escherichia coli and Staphylococcus aureus.

Breast cancer patients struggle with several unmet emotional and financial concerns

Although breast cancer is the most common non-skin cancer diagnosed in women, finding support during treatment and through survivorship can be incredibly challenging.

October 18, 2024

Compass Pathways and Journey Clinical Establish Research Collaboration Agreement To Inform the Training of Healthcare Providers and Delivery Model for COMP360 Psilocybin Treatment, If Approved for Treatment-Resistant Depression | Psychedelic Invest

LONDON, April 29, 2024 (GLOBE NEWSWIRE) — Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in

April 29, 2024

AD/PD 2024: exploring cutting-edge therapies for ALS – Pharmaceutical Technology

Share this article The ALS treatment landscape includes therapies with different mechanisms, but they are not curative, prompting the need for disease-modifying therapies. Credit: Shutterstock/Juan

March 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.